Pierre Gagnon
Net worth: - $ as of 30/04/2024
Profile
Mr. Pierre Gagnon is a Chief Operating Officer at NKGen Biotech, Inc. He is on the Board of Directors at ATGen Canada, Inc. Mr. Gagnon was previously employed as a Chief Operating Officer by NKGen Biotech, Inc. /US/ and a Director-Global Operations & Director by NKMAX Co., Ltd.
He received his undergraduate degree from the University of Quebec.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 29/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Pierre Gagnon active positions
| Companies | Position | Start |
|---|---|---|
| ATGen Canada, Inc. | Director/Board Member | 01/05/2013 |
Former positions of Pierre Gagnon
| Companies | Position | End |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Chief Operating Officer | 01/09/2023 |
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Chief Operating Officer | 01/06/2019 |
Training of Pierre Gagnon
| University of Quebec | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| ATGen Canada, Inc. | |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
- Stock Market
- Insiders
- Pierre Gagnon
